- Start Date:To End Date:
3rd International Global Cancer Consortium Conference
The details of the conference are available in the attached brochure and website: https://glocacon.org/event/3rd-international-global-cancer-consortium-conference-2/
Dates To Remember
Registration and Abstract submission deadline has been extended to January 15, 2024.
------------------------------------------------------------------
The 3rd International GCC conference on “Current Trends in Tumor Microenvironment and Therapeutics" coupled with a “Humanized Mice Workshop” organized by the GCC-South Asia Chapter” will be held on February 3-5, 2023, at ACTREC/Tata Memorial Centre, Kharghar, Navi Mumbai, Maharashtra, India.
The distinguished speakers are invited from India, USA, Europe, Brazil, Australia, japan and other parts of Asia to share their expertise and insights. A flyer for the conference is attached. The presentations by international experts and discussions on the latest advances in tumor micro-environment will lead to collaborations in scientific research and education as one of the important goals of this conference. A demonstration workshop on “Humanized Mice generation and applications” will provide participants with in-depth knowledge about experimental details, data analysis, and interpretation in immunomodulatory drug testing (CAR-T or Immune checkpoint inhibitors/herbal-based) using the cutting-edge models.
This is the 3rd international conference organized by the Global Cancer Consortium. The details about the consortium and GCC-South Asia Chapter and its educational and research activities can be found at www.glocacon.org. The audience will include scientists, clinicians, graduate students, and postdoctoral fellows from academic and industrial sectors across India and several institutions from USA, Asia, Europe, and Africa.
The meeting aims to highlight recent advances in all major areas of the Tumor Microenvironment, Tumor Immune Microenvironment, Extracellular Matrix Interactions, Cancer Fibroblasts and Signaling and Humanized Mice and applications for Immunotherapy Drug Development. This conference will showcase the progress made in these areas and will highlight new therapeutic interventions in cancer and mechanistic aspects. Specific sessions, panel discussions, and oral and poster presentations from young researchers are proposed to promote interactions and networking during the meeting.
We will consider publishing a conference report alongwith abstracts and selected proceeding papers in a reputed journal.
